Skip to main content

Advertisement

Table 1 (abstract P195). Biologic medication according to JIA cathegory.

From: Proceedings of the 25th European Paediatric Rheumatology Congress (PReS 2018)

Type of medication Registrations* Systemic JIA* Poly (RF neg) JIA* Poly (RF pos) JIA* Oligo (persistent) JIA* Oligo (extending) JIA* Enthesitis related JIA* Psoriatic  JIA* Undifferentiated JIA*
Registrations, total 1047 (100) 231 (21) 363 (35) 98 (9) 113 (11) 138 (13) 66 (6) 31 (3) 7 (1)
Etanercept 490 (47) 34 (7) 177 (36) 63 (13) 45 (9) 94 (19) 54 (11) 21 (4) 2 (0.4)
Infliximab 91 (9) 10 (11) 34 (37) 12 (13) 24 (26) 4 (4) - 4 (4) 3 (3)
Adalimumab 219 (21) 15 (7) 104 (48) 15 (7) 41 (19) 24 (11) 12 (6) 6 (3) 2 (1)
Anakinra 45 (4) 42 (93) 3 (7) - - - - - -
Tocilizumab 155 (15) 109 (70) 34 (22) 6 (4) 1 (0.6) 5 (3) - - -
Abatacept 24 (2) 6 (25) 7 (29) 2 (8) 2 (8) 7 (29) - - -
Other 26 (2) 18 (69) 4 (15) - - 4 (15) - - -
  1. *Numbers of registrations (%)